CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,092
- in 3 filings, $19K under 10b5-1 plans
Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Chatterjee Meeta Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-05-17 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award | +77,900 | 77,900 | ||
| 2023-05-17 | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +155,800 | 155,800 | ||
| 2023-05-11 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −949 | $9.87 | $9K | 106,610 |
| 2023-05-11 | Eaton Bruce EVP, CBO AND CTO | Sale 10b5-1 | −668 | $9.87 | $7K | 76,779 |
| 2023-05-09 | Eaton Bruce EVP, CBO AND CTO | Sale 10b5-1 | −135 | $9.51 | $1K | 77,447 |
| 2023-04-11 | Levy Elliott M. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-03-03 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −184 | $8.89 | $2K | 107,559 |
| 2023-03-03 | Eaton Bruce EVP, CBO AND CTO | Sale | −101 | $8.89 | $898 | 77,582 |
| 2023-03-02 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Grant or award | +31,500 | 107,743 | ||
| 2023-03-02 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +94,500 | 94,500 | ||
| 2023-03-02 | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Grant or award | +18,000 | 76,372 | ||
| 2023-03-02 | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +54,000 | 54,000 | ||
| 2023-03-02 | O'Neill Gilmore Neil CEO | Grant or award | +50,000 | 136,655 | ||
| 2023-03-02 | O'Neill Gilmore Neil CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-03-02 | Eaton Bruce EVP, CBO AND CTO | Grant or award | +16,700 | 77,683 | ||
| 2023-03-02 | Eaton Bruce EVP, CBO AND CTO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-02-13 | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | Sale | −2,790 | $9.67 | $27K | 65,559 |
| 2023-02-13 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −4,287 | $9.67 | $41K | 76,243 |
| 2023-02-13 | Eaton Bruce EVP, CBO AND CTO | Sale | −3,307 | $9.67 | $32K | 60,983 |
Page 6 of 15 · 283 trades